Bio-Combination 25 (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the Bio-Combination 25 drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, SILICEA
SUBSTANCE NAME: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SILICON DIOXIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00


Bio-Combination 25 HUMAN OTC DRUG Details:

Item DescriptionBio-Combination 25 from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 12([hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-2380_f4a2d4e6-a0f9-4163-b8fe-3782fcf052f1
PRODUCT NDC: 15631-2380
APPLICATION NUMBER:

Other SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SILICON DIOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncBio-Combination 25